J. Lewis

M. Welch, J. Lewis, 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Clinical significance of low-positive troponin I by AxSYM and ACS:180.

J. Lewis, M. Creer, Katherine S. Virgo, 2001, American journal of clinical pathology.

High purity production and potential applications of copper-60 and copper-61.

P. Cutler, P. Herrero, M. Welch, 1999, Nuclear medicine and biology.

Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats.

P. Cutler, Jason S. Lewis, J. Lewis, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Toxicity and dosimetry of 177Lu‐DOTA‐Y3‐octreotate in a rat model

R. Laforest, J. Lewis, J. Erion, 2001, International journal of cancer.

Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.

Y. Fujibayashi, M. Welch, J. Lewis, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake.

J. Lewis, C. Anderson, A. Srinivasan, 1999, Nuclear medicine and biology.

Recurrence in the axilla after sentinel lymph node biopsy for breast cancer.

J. Lewis, K. Clough, R. Salmon, 2002, European Journal of Surgical Oncology.

Copper radionuclides and radiopharmaceuticals in nuclear medicine.

J. Lewis, P. Blower, J. Zweit, 1996, Nuclear medicine and biology.

Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.

T. Buettner, Y. Fujibayashi, M. Welch, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Effects of natural and synthetic polyamines on the conformation of an oligodeoxyribonucleotide with the estrogen response element.

T. Thomas, M. Gallo, N. Greenfield, 1997, Nucleic acids research.

Seromucinous Hamartoma of the Nasal Cavity: A Report of Two Cases and Review of the Literature

R. Chernock, J. Lewis, R. A. Khan, 2011, Head and neck pathology.

Regulation of cell cycle and cyclins by 16alpha-hydroxyestrone in MCF-7 breast cancer cells.

M. Gallo, C. Klinge, T. Thomas, 2001, Journal of molecular endocrinology.

Regulation of cell cycle and cyclins by 16 -hydroxyestrone in MCF-7 breast cancer cells

M. Gallo, C. Klinge, T. Thomas, 2001 .

Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis

Ping Liu, M. Yeager, L. Mirabello, 2021, medRxiv.

Expression of vascular endothelial growth factor by macrophages is up‐regulated in poorly vascularized areas of breast carcinomas

A. Harris, C. Lewis, J. Lewis, 2000, The Journal of pathology.

Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal

V. Jordan, V. Jordan, C. Osipo, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in mice.

G. Nolan, J. Lewis, F. Scappaticci, 2003, Vaccine.

Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx.

J. Shah, D. Kallogjeri, J. Piccirillo, 2016, Oral oncology.

Production of non-standard PET radionuclides and the application of radiopharmaceuticals labeled with these nuclides.

M J Welch, R Laforest, M. Welch, 2007, Ernst Schering Research Foundation workshop.

Peritoneal disease in breast cancer: A specific entity with an extremely poor prognosis.

J. Stebbing, J. Lewis, R. Leonard, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.

F Dehdashti, J. Lewis, F. Dehdashti, 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.

S Mutic, M J Welch, J F Dempsey, 2001, International journal of radiation oncology, biology, physics.

The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer.

J. Stebbing, J. Lewis, A. Lalvani, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.

R Laforest, F Dehdashti, P. Cutler, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Self-assembly of an oligodeoxyribonucleotide harboring the estrogen response element in the presence of polyamines: ionic, structural, and DNA sequence specificity effects.

T. Thomas, J. Lewis, T. Thomas, 2000, Biomacromolecules.

Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogs in a tumor-bearing rat model.

R Laforest, R. Laforest, J. Lewis, 2000, Cancer biotherapy & radiopharmaceuticals.

Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy.

J. Lewis, C. Anderson, J. Wang, 1999, Journal of medicinal chemistry.

Workshop on the production, application and clinical translation of ''non-standard'' PET nuclides: a meeting report.

M J Welch, M. Welch, J. Lewis, 2008, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....